Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.1 (
RNase
)
16,360
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cortical midline glia are critical to the formation of the corpus callosum during development. The glial wedge is a population of midline glia that is located at the corticoseptal boundary and expresses repulsive/growth-inhibitory molecules that guide callosal axons as they cross the midline. The glial wedge are the first cells within the cortex to express GFAP and thus may express molecules specific for glial maturation. The corticoseptal boundary is a genetically defined boundary between the cingulate cortex (dorsal telencephalon) and the septum (ventral telencephalon). The correct dorso-ventral position of this boundary is vital to the formation of both the glial wedge and the corpus callosum. Our aim was to identify genes expressed specifically within the glial wedge that might be involved in either glial differentiation, formation of the corticoseptal boundary or development of the corpus callosum. To identify such genes we have performed a differential display PCR screen comparing RNA isolated from the glial wedge with RNA isolated from control tissues such as the neocortex and septum, of embryonic day 17 mouse brains. Using 200 different combinations of primers, we identified and cloned 67 distinct gene fragments. In situ hybridization analysis confirmed the differential expression of many of the genes, and showed that clones G24F3, G39F8 and transcription factor LZIP have specific expression patterns in the telencephalon of embryonic and postnatal brains. An
RNase
Protection Assay (RPA) revealed that the expression of G39F8, G24F3 and
LZIP
increase markedly in the telencephalon at E16 and continue to be expressed until at least P0, during the period when the corpus callosum is forming.
...
PMID:Identification of candidate genes at the corticoseptal boundary during development. 1645 80
Chemokines and chemokine receptors play a role in migration of circulating leukocytes to the region of inflammation. Human
LZIP
is an uncharacterized transcription factor and is known to participate in leukotactin (Lkn)-1/CCL15-induced cell migration. We investigated the role of human
LZIP
in expression of CC chemokine receptors (CCRs) and its involvement in monocyte migration.
RNase
protection analysis showed that
LZIP
increased mRNA expression of CCR2 and CCR1 in THP-1 cells. Surface expressions of both CCR2 and CCR1 were also increased by
LZIP
. Results from an electrophoretic mobility shift assay showed that
LZIP
binds to the C/EBP element in the CCR2 promoter.
LZIP
also enhanced the chemotactic activities of monocyte chemoattractant protein-1/CCL2 and Lkn-1. These results suggest that
LZIP
regulates expression of chemokine receptors that are involved in monocyte migration.
...
PMID:Human LZIP induces monocyte CC chemokine receptor 2 expression leading to enhancement of monocyte chemoattractant protein 1/CCL2-induced cell migration. 1858 71